The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1 ...
PhRMA, a leading drug industry trade group, and the US Chamber of Commerce have also filed suits. More on Medicare drug pricing: Medicare lists first ten drugs selected for pricing negotiations ...
Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...
While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price negotiations ...
AARP announced Thursday it would join the US government in two additional lawsuits brought by drug companies suing over Medicare drug pricing negotiations, which are set to begin next month.
Each candidate had a half hour to answer questions from a moderator about their economic plan ahead of the general election.
A group of Republicans has called the Biden administration's list of the first 10 drugs that will face Medicare price negotiations a form of price controls that will end up leading to fewer new ...
AstraZeneca joins Johnson & Johnson (), Merck (), and Bristol-Myers in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President ...
In fact, the ministry had not responded to the chamber's questions at that point, and within the 30 days it is statutorily required to. ERR News has reproduced, together with links to the relevant ...
Dubai Chamber of Commerce, one of the three chambers operating under the umbrella of Dubai Chambers, has revealed that Indian investors topped the list of nationalities behind new companies joining ...
Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...
AARP announced Thursday it would join the US government in two additional lawsuits brought by drug companies suing over Medicare drug pricing negotiations, which are set to begin next month.
